Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, Miguel A Merlos Rodrigo, Marta Bento Afonso, Mikel Azkargorta, Leidy Estefanía Zapata-Pavas, Claudia M Rejano-Gordillo, Marta R Romero, Isabel Mendizabal, Pedro M Rodrigues, Hanghang Wu, Rubén Rodríguez-Agudo, Marina Serrano-Maciá, Paula Olaizola, Jon Ander Barrenechea-Barrenechea, Irene González Recio, Maite G Fernandez-Barrena, Diletta Overi, Eugenio Gaudio, Ute Schaeper, Saioa Garcia-Longarte, Mariana Yáñez-Bartolomé, Patricia Peña-SanFelix, Clàudia Gil-Pitarch, Ainhoa Lapitz, Hana Michalkova, Zbynek Heger, Carolina Conter, Rocio I R Macias, Arkaitz Carracedo, Jesús Bañales, Victor Moreno, Angela Lamarca, Rajat Singh, Teresa Cardoso Delgado, Luis Alfonso Martínez-Cruz, Felix Elortza, Matias A Avila, César Martín, Tian V. Tian, Teresa Macarulla, Daniela Buccella, Francisco Javier Cubero, Diego F Calvisi, Guido Carpino, Jose J G Marin, Cecília M P Rodrigues, Maria Luz Martinez-Chantar
{"title":"Role of CNNM4 in the progression of cholangiocarcinoma: implications for ferroptosis and therapeutic potential","authors":"Maria Mercado-Gómez, Naroa Goikoetxea-Usandizaga, Alvaro Eguileor Giné, Miguel A Merlos Rodrigo, Marta Bento Afonso, Mikel Azkargorta, Leidy Estefanía Zapata-Pavas, Claudia M Rejano-Gordillo, Marta R Romero, Isabel Mendizabal, Pedro M Rodrigues, Hanghang Wu, Rubén Rodríguez-Agudo, Marina Serrano-Maciá, Paula Olaizola, Jon Ander Barrenechea-Barrenechea, Irene González Recio, Maite G Fernandez-Barrena, Diletta Overi, Eugenio Gaudio, Ute Schaeper, Saioa Garcia-Longarte, Mariana Yáñez-Bartolomé, Patricia Peña-SanFelix, Clàudia Gil-Pitarch, Ainhoa Lapitz, Hana Michalkova, Zbynek Heger, Carolina Conter, Rocio I R Macias, Arkaitz Carracedo, Jesús Bañales, Victor Moreno, Angela Lamarca, Rajat Singh, Teresa Cardoso Delgado, Luis Alfonso Martínez-Cruz, Felix Elortza, Matias A Avila, César Martín, Tian V. Tian, Teresa Macarulla, Daniela Buccella, Francisco Javier Cubero, Diego F Calvisi, Guido Carpino, Jose J G Marin, Cecília M P Rodrigues, Maria Luz Martinez-Chantar","doi":"10.1136/gutjnl-2024-333255","DOIUrl":null,"url":null,"abstract":"Background and objective Cholangiocarcinoma (CCA) is a heterogeneous neoplasm of the biliary epithelium that easily infiltrates, metastasises and recurs. Magnesium disbalance is a hallmark of CCA, with the magnesium transporter cyclin M4 (CNNM4) being a key driver of various hepatic diseases. This study aims to unravel the role of CNNM4 in the initiation and progression of CCA. Design CNNM4 protein and gene expression were assessed in vitro, in vivo and in patients with CCA. Silencing of CNNM4 was effectively achieved by using small interfering RNA (siRNA) or short hairpin RNA in CCA cell lines and GalNAc-conjugated siRNA in a transposon-based CCA mice model. The impact of CNNM4 on tumour cell proliferation, migration and invasion to the lungs was evaluated using the chicken chorioallantoic membrane model. Proteomic analysis was employed to elucidate the underlying molecular mechanisms. Results CNNM4 was upregulated in CCA samples from humans, mice and cell lines. Functional studies demonstrated that CNNM4 deficiency attenuates cell growth, chemoresistance, migration, invasion, cancer stem cell properties and Warburg effect in vitro and in vivo. Proteomic analysis identified nuclear protein 1 as an upstream regulator of CNNM4-induced ferroptosis in CCA, ultimately leading to cell death. The iron chelator deferiprone could reverse the decreased proliferation induced by CNNM4 silencing, while inhibition of the heme oxygenase-1 by zinc protoporphyrin IX affected only the growth of cells with no targeted CNNM4 inhibition, highlighting the specificity of ferroptosis in CNNM4-associated effects. Conclusion This study reveals that increased CNNM4 expression drives CCA progression and malignancy and that its inhibition may be an effective therapeutic strategy to limit proliferation and metastasis in patients with CCA. All data relevant to the study are included in the article or uploaded as supplementary information.","PeriodicalId":12825,"journal":{"name":"Gut","volume":"10 1","pages":""},"PeriodicalIF":25.8000,"publicationDate":"2025-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gut","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1136/gutjnl-2024-333255","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background and objective Cholangiocarcinoma (CCA) is a heterogeneous neoplasm of the biliary epithelium that easily infiltrates, metastasises and recurs. Magnesium disbalance is a hallmark of CCA, with the magnesium transporter cyclin M4 (CNNM4) being a key driver of various hepatic diseases. This study aims to unravel the role of CNNM4 in the initiation and progression of CCA. Design CNNM4 protein and gene expression were assessed in vitro, in vivo and in patients with CCA. Silencing of CNNM4 was effectively achieved by using small interfering RNA (siRNA) or short hairpin RNA in CCA cell lines and GalNAc-conjugated siRNA in a transposon-based CCA mice model. The impact of CNNM4 on tumour cell proliferation, migration and invasion to the lungs was evaluated using the chicken chorioallantoic membrane model. Proteomic analysis was employed to elucidate the underlying molecular mechanisms. Results CNNM4 was upregulated in CCA samples from humans, mice and cell lines. Functional studies demonstrated that CNNM4 deficiency attenuates cell growth, chemoresistance, migration, invasion, cancer stem cell properties and Warburg effect in vitro and in vivo. Proteomic analysis identified nuclear protein 1 as an upstream regulator of CNNM4-induced ferroptosis in CCA, ultimately leading to cell death. The iron chelator deferiprone could reverse the decreased proliferation induced by CNNM4 silencing, while inhibition of the heme oxygenase-1 by zinc protoporphyrin IX affected only the growth of cells with no targeted CNNM4 inhibition, highlighting the specificity of ferroptosis in CNNM4-associated effects. Conclusion This study reveals that increased CNNM4 expression drives CCA progression and malignancy and that its inhibition may be an effective therapeutic strategy to limit proliferation and metastasis in patients with CCA. All data relevant to the study are included in the article or uploaded as supplementary information.
期刊介绍:
Gut is a renowned international journal specializing in gastroenterology and hepatology, known for its high-quality clinical research covering the alimentary tract, liver, biliary tree, and pancreas. It offers authoritative and current coverage across all aspects of gastroenterology and hepatology, featuring articles on emerging disease mechanisms and innovative diagnostic and therapeutic approaches authored by leading experts.
As the flagship journal of BMJ's gastroenterology portfolio, Gut is accompanied by two companion journals: Frontline Gastroenterology, focusing on education and practice-oriented papers, and BMJ Open Gastroenterology for open access original research.